{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T10:41:57Z","timestamp":1765276917102,"version":"3.46.0"},"reference-count":18,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2020-0105_abs_001_w2aab3b7b7b1b6b1aab1c14b2Aa\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The impact of insurance status on oncological outcome in patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2020-0105_abs_002_w2aab3b7b7b1b6b1aab1c14b3Aa\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective study on 31 patients having undergone 36 CRS-HIPEC at a single institution (safety-net hospital) between 2012 and 2018. Patients were categorized as insured or underinsured. Demographics and perioperative events were compared. Primary outcome was overall survival (OS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2020-0105_abs_003_w2aab3b7b7b1b6b1aab1c14b4Aa\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 20 patients were underinsured and 11 were insured. There were less gynecologic malignancies in the underinsured (p=0.02). On univariate analysis, factors linked to poor survival included gastrointestinal (p=0.01) and gynecologic malignancies (p=0.046), treatment with neoadjuvant chemotherapy (p=0.03), CC1 (p=0.02), abdominal wall resection (p=0.01) and Clavien\u2013Dindo 3-4 (p=0.01). Treatment with neoadjuvant chemotherapy and abdominal wall resections, but not insurance status, were independently associated with OS (p=0.01, p=0.02 respectively). However, at the end of follow-up, six patients were alive in the insured group vs. zero in the underinsured group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2020-0105_abs_004_w2aab3b7b7b1b6b1aab1c14b5Aa\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this small, exploratory study, there was no statistical difference in OS between insured and underinsured patients after CRS-HIPEC. However, long-term survivors were observed only in the insured group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2020-0105","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T03:03:00Z","timestamp":1597719780000},"source":"Crossref","is-referenced-by-count":6,"title":["Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)"],"prefix":"10.1515","volume":"5","author":[{"given":"Ravi J.","family":"Chokshi","sequence":"first","affiliation":[{"name":"Division of Surgical Oncology , Rutgers New Jersey Medical School , Newark , NJ , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4373-1431","authenticated-orcid":false,"given":"Jin K.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery , Rutgers New Jersey Medical School , Newark , NJ , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Surgery , Rutgers New Jersey Medical School , Newark , NJ , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph B.","family":"Oliver","sequence":"additional","affiliation":[{"name":"Department of Surgery , Rutgers New Jersey Medical School , Newark , NJ , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology , Rutgers New Jersey Medical School , Newark , NJ , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"2025120909205927780_j_pp-2020-0105_ref_001_w2aab3b7b7b1b6b1ab2b2b1Aa","doi-asserted-by":"crossref","unstructured":"Sugarbaker, PH. Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment. Langenbecks Arch Chir 1988;373:189\u201396. https:\/\/doi.org\/10.1007\/bf01274232.","DOI":"10.1007\/BF01274232"},{"key":"2025120909205927780_j_pp-2020-0105_ref_002_w2aab3b7b7b1b6b1ab2b2b2Aa","unstructured":"Neuwirth, MG, Alexander, HR, Karakousis, GC. Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective. J Gastrointest Oncol 2016;7:18\u201328. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.106."},{"key":"2025120909205927780_j_pp-2020-0105_ref_003_w2aab3b7b7b1b6b1ab2b2b3Aa","doi-asserted-by":"crossref","unstructured":"Walker, GV, Grant, SR, Guadagnolo, BA, Hoffman, KE, Smith, BD, Koshy, M, et al. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status. J Clin Oncol 2014;32:3118\u201325. https:\/\/doi.org\/10.1200\/jco.2014.55.6258.","DOI":"10.1200\/JCO.2014.55.6258"},{"key":"2025120909205927780_j_pp-2020-0105_ref_004_w2aab3b7b7b1b6b1ab2b2b4Aa","doi-asserted-by":"crossref","unstructured":"Grant, SR, Walker, GV, Guadagnolo, BA, Koshy, M, Allen, PK, Mahmood, U. Variation in insurance status by patient demographics and tumor site among nonelderly adult patients with cancer. Cancer 2015;121:2020\u20138. https:\/\/doi.org\/10.1002\/cncr.29120.","DOI":"10.1002\/cncr.29120"},{"key":"2025120909205927780_j_pp-2020-0105_ref_005_w2aab3b7b7b1b6b1ab2b2b5Aa","doi-asserted-by":"crossref","unstructured":"P\u00f6lcher, M, Zivanovic, O, Chi, DS. Cytoreductive surgery for advanced ovarian cancer. Wom Health 2014;10:179\u201390. https:\/\/doi.org\/10.2217\/WHE.14.4.","DOI":"10.2217\/WHE.14.4"},{"key":"2025120909205927780_j_pp-2020-0105_ref_006_w2aab3b7b7b1b6b1ab2b2b6Aa","unstructured":"Pretorius, RG, Petrilli, ES, Kean, CK. Comparison of the iv and ip routes of administration of cisplatin in dogs. Canc Treat Rep 1981;65:1055\u201362."},{"key":"2025120909205927780_j_pp-2020-0105_ref_007_w2aab3b7b7b1b6b1ab2b2b7Aa","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Moreno, S, Gonz\u00e1lez-Bay\u00f3n, LA, Ortega-P\u00e9rez, G. Hyperthermic intraperitoneal chemotherapy: rationale and technique. World J Gastrointest Oncol 2010;15:68\u201375. https:\/\/doi.org\/10.4251\/wjgo.v2.i2.68.","DOI":"10.4251\/wjgo.v2.i2.68"},{"key":"2025120909205927780_j_pp-2020-0105_ref_008_w2aab3b7b7b1b6b1ab2b2b8Aa","doi-asserted-by":"crossref","unstructured":"Tabrizian, P, Overbey, J, Carrasco-Avino, G, Bagiella, E, Labow, DM, Sarpel, U. Escalation of socioeconomic disparities among patients with colorectal cancer receiving advanced surgical treatment. Ann Surg Oncol 2015;22:1746\u201350. https:\/\/doi.org\/10.1245\/s10434-014-4220-6.","DOI":"10.1245\/s10434-014-4220-6"},{"key":"2025120909205927780_j_pp-2020-0105_ref_009_w2aab3b7b7b1b6b1ab2b2b9Aa","doi-asserted-by":"crossref","unstructured":"Morano, WF, Khalili, M, Chi, DS, Bowne, WB, Esquivel, J, Clinical studies in CRS and HIPEC: trials, tribulations, and future directions-a systematic review. J Surg Oncol 2018;117:245\u201359. https:\/\/doi.org\/10.1002\/jso.24813.","DOI":"10.1002\/jso.24813"},{"key":"2025120909205927780_j_pp-2020-0105_ref_010_w2aab3b7b7b1b6b1ab2b2c10Aa","doi-asserted-by":"crossref","unstructured":"Oliver, JB, Son, JY, Bongu, A, Anandalwar, SP, Chokshi, RJ. Colorectal cancer disparities at an urban tertiary care center. Am Surg 2016;82:181\u20133.","DOI":"10.1177\/000313481608200225"},{"key":"2025120909205927780_j_pp-2020-0105_ref_011_w2aab3b7b7b1b6b1ab2b2c11Aa","doi-asserted-by":"crossref","unstructured":"Leiting, JL, Grotz, TE. Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis. World J Gastrointest Oncol 2018;10:282\u20139. https:\/\/doi.org\/10.4251\/wjgo.v10.i10.282.","DOI":"10.4251\/wjgo.v10.i10.282"},{"key":"2025120909205927780_j_pp-2020-0105_ref_012_w2aab3b7b7b1b6b1ab2b2c12Aa","doi-asserted-by":"crossref","unstructured":"Belli, S, Aytac, HO, Karagulle, E, Yabanoglu, H, Kayaselcuk, F, Yildirim, S. Outcomes of surgical treatment of primary signet ring cell carcinoma of the colon and rectum: 22 cases reviewed with literature. Int Surg 2014;99:691\u20138. https:\/\/doi.org\/10.9738\/intsurg-d-14-00067.1.","DOI":"10.9738\/INTSURG-D-14-00067.1"},{"key":"2025120909205927780_j_pp-2020-0105_ref_013_w2aab3b7b7b1b6b1ab2b2c13Aa","doi-asserted-by":"crossref","unstructured":"Verwaal, VJ, van Tinteren, H, van Ruth, S, Zoetmulder, FA. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004;91:739\u201346. https:\/\/doi.org\/10.1002\/bjs.4516.","DOI":"10.1002\/bjs.4516"},{"key":"2025120909205927780_j_pp-2020-0105_ref_014_w2aab3b7b7b1b6b1ab2b2c14Aa","doi-asserted-by":"crossref","unstructured":"Jafari, MD, Halabi, WJ, Stamos, MJ, Nguyen, VQ, Carmichael, JC, Mills, SD, et al. Surgical outcomes of hyperthermic intraperitoneal chemotherapy analysis of the American College of Surgeons National Surgical Quality Improvement Program. JAMA Surg 2014;149:170\u20135.","DOI":"10.1001\/jamasurg.2013.3640"},{"key":"2025120909205927780_j_pp-2020-0105_ref_015_w2aab3b7b7b1b6b1ab2b2c15Aa","doi-asserted-by":"crossref","unstructured":"Piso, P, Nedelcut, SD, Rau, B, K\u00f6nigsrainer, A, Glockzin, G, Str\u00f6hlein, MA, et al. Morbidity and mortality following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: data from the DGAV StuDoQ registry with 2149 consecutive patients. Ann Surg Oncol 2019;26:148\u201354. https:\/\/doi.org\/10.1245\/s10434-018-6992-6.","DOI":"10.1245\/s10434-018-6992-6"},{"key":"2025120909205927780_j_pp-2020-0105_ref_016_w2aab3b7b7b1b6b1ab2b2c16Aa","doi-asserted-by":"crossref","unstructured":"Fava, BEC, da Costa, WL, Medeiros, MLL, Sonagli, M, de Castro Ribeiro, HS, Diniz, AL, et al. Neoadjuvant intraperitoneal chemotherapy followed by radical surgery and HIPEC in patients with very advanced gastric cancer and peritoneal metastases: report of an initial experience in a western single center. World J Surg Oncol 2018;62. https:\/\/doi.org\/10.1186\/s12957-018-1363-0.","DOI":"10.1186\/s12957-018-1363-0"},{"key":"2025120909205927780_j_pp-2020-0105_ref_017_w2aab3b7b7b1b6b1ab2b2c17Aa","doi-asserted-by":"crossref","unstructured":"Batista, TP, Carneiro, VCG, Tancredi, R, Teles, ALB, Badiglian-Filho, L, Le\u00e3o, CS. Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach. Canc Manag Res 2017;9:869\u201378. https:\/\/doi.org\/10.2147\/cmar.s153327.","DOI":"10.2147\/CMAR.S153327"},{"key":"2025120909205927780_j_pp-2020-0105_ref_018_w2aab3b7b7b1b6b1ab2b2c18Aa","doi-asserted-by":"crossref","unstructured":"Nunez, MF, Sardi, A, Nieroda, C, Jimenez, W, Sittig, M, MacDonald, R, et al. Morbidity of the abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC). Ann Surg Oncol 2015;22:1658\u201363. https:\/\/doi.org\/10.1245\/s10434-014-4075-x.","DOI":"10.1245\/s10434-014-4075-x"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/5\/3\/article-20200105.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2020-0105\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2020-0105\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T10:40:03Z","timestamp":1765276803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2020-0105\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,8,25]]},"published-print":{"date-parts":[[2020,9,4]]}},"alternative-id":["10.1515\/pp-2020-0105"],"URL":"https:\/\/doi.org\/10.1515\/pp-2020-0105","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"type":"electronic","value":"2364-768X"},{"type":"print","value":"2364-7671"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"article-number":"20200105"}}